Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

New England Journal of Medicine

Volumn 350, Issue 19, 2004, Pages 1945-1952

  Bernier, Jacques ^a,m   Domenge, Christian ^b   Ozsahin, Mahmut ^c   Matuszewska, Katarzyna ^d   Lefèbvre, Jean Louis ^e   Greiner, Richard H ^f   Giralt, Jordi ^g   Maingon, Philippe ^h   Rolland, Frédéric ⁱ   Bolla, Michel ^j   Cognetti, Francesco ^k   Bourhis, Jean ^b   Kirkpatrick, Anne ^l   Van Glabbeke, Martine ^l  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e Centre O Lambret   (France)

^f UNIVERSITY OF BERN   (Switzerland)

^g HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^h CENTRE GEORGES FRANÇOIS LECLERC   (France)

ⁱ CENTRE RENÉ GAUDUCHEAU   (France)

^j HÔPITAL MICHALLON   (France)

^k REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^l Europ Organisation Res Treatm C   (Belgium)

^m SAN GIOVANNI HOSPITAL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BONE DISEASE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CERVICOBRACHIAL NEURALGIA; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; LARYNX DISORDER; LYMPHATIC SYSTEM DISEASE; MAJOR CLINICAL STUDY; MALE; MUCOSAL NECROSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIATION DOSE; SKIN FIBROSIS; XEROSTOMIA; ADOLESCENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; HEAD AND NECK TUMOR; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RISK; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIOTHERAPY; RISK; SURVIVAL RATE;

EID: 2342592623     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa032641     Document Type: Article

References (34)

1. Johnson JT, Barnes EL, Myers EN, Scrahmm VL Jr, Borochovitz D, Sigler BA. The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 1981; 107:725-9.
2. Kramer S, Gelber RD, Snow JB, et al. Combined radiation therapy and surgery in the management of head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg 1987;10:19-30.
3. Snow GB, Annyas AA, van Slooten EA, Barterlink H, Hart AA. Prognostic factors of neck node metastasis. Clin Otolaryngol 1982;7:185-92.
4. Vikram B, Strong EW, Shah JP, Spiro R. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg 1984;6:720-3.
5. Fletcher GH, Evers WT. Radiotherapeutic management of surgical recurrences and postoperative residuals in tumors of the head and neck. Radiology 1970;95:185-8.
6. Tupchong L, Scott CB, Blitzer PH, et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 1991;20:21-8.
7. Cachin Y, Eschwege F. Combination of radiotherapy and surgery in the treatment of head and neck cancers. Cancer Treat Rev 1975;2:177-91.
8. Stell PM, Rawson NS. Adjuvant chemotherapy in head and neck cancer. Br J Cancer 1990;61:779-87.
9. Jassem J, Bartelink H. Chemotherapy in locally advanced head and neck cancer: a critical reappraisal. Cancer Treat Rev 1995;21: 447-62.
10. Jacobs C, Makuch R. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of Head and Neck Contracts Program. J Clin Oncol 1990;8:838-47.
11. Laramore GE, Scott CB, al-Sarraf M, et al. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. Int j Radiat Oncol Biol Phys 1992;23:705-13.
12. Bachaud JM, David JM, Boussin G, Daly N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck preliminary report of a randomized trial. Int J Radiat Oncol Biol Phys 1991; 20:243-6.
13. Haffty BG, Son YH, Sasaki CT, et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys 1993;27:241-50.
14. Spiessl B, Beahrs OH, Hermanek P, et al., eds. TNM atlas: illustrated guide to the TNM/ pTNM-classification of malignant tumours. 3rd ed. Berlin. Springer-Verlag, 1989.
15. Robbins KT, Medina JB, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology: official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg 1991;117:601-5.
16. Bernier J, Wibault P, Eschwege F, et al. Interim analysis of EORTC Phase III Trial 22931: after surgery, chemo-radiation (CRT), as compared to radiotherapy alone (RT), significantly increases disease-free survival (DFS), local control (LC) and overall survival (OS) in high-risk head and neck cancer (HNSCC) patients. Ann Oncol 2002;13:Suppl 5:9. abstract.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
19. Barkley HT, Fletcher GH, Jesse RH, Lindberg RD. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg 1972;124:462-7.
20. Peters LJ, Goepfert H, Ang KK, et al. Evaluation of the dose for post-operative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993;26:3-11.
21. Rossi A, Molinari R, Boracchi P, et al. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J Clin Oncol 1988;6: 1401-10.
22. Szpirglas H, Chastang CL, Bertrand JC. Adjuvant treatment of tongue and floor of the mouth cancer. Cancer Res 1978;68: 309-17.
23. Huang AT, Cole TB, Fishburn R, Jelovsek SB. Adjuvant chemotherapy after surgery and radiation for stage III and IV head and neck cancer. Ann Surg 1984;200:195-9.
24. Jacobs JR, Pajak TF, al-Sarraf M, et al. Chemotherapy following surgery for head and neck cancer: a Radiation Therapy Oncology Group study. Am J Clin Oncol 1989; 12:185-9.
25. Johnson JT, Myers EN, Schramm VL Jr, et al. Adjuvant chemotherapy for high-risk squamous-cell carcinomas of the head and neck. J Clin Oncol 1987;5:456-8.
26. Al-Sarraf M, Pajak TF, Marcial VA, et al. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck: an RTOG study. Cancer 1987;59:259-65.
27. Merlano M, Benasso M, Corvo R, et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996;88:583-9.
28. Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996;365:999-1004.
29. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-804.
30. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998;16:1318-24.
31. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91:2081-6.
32. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949-55.
33. Adelstein DJ, Rice TW, Rybicki LA, et al. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol 2000;18:2032-9.
34. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44.